CVRx (CVRX) Current Leases (2022 - 2026)

CVRx (CVRX) recorded quarterly Current Leases of $361000.0 in Q1 2026, up 2.56% quarter-over-quarter from $352000.0 in Q4 2025, and up 24.48% on a YoY basis from $290000.0 in Q1 2025.

CVRx (CVRX) Current Leases (2022 - 2026) Analysis & Trends

CVRx's Current Leases history runs 5 years deep, the most recent figure standing at $361000.0 for Q1 2026.

  • In Q1 2026, Current Leases rose 24.48% year-over-year to $361000.0; the TTM figure through Mar 2026 stood at $361000.0 (up 24.48% YoY), while the FY2025 annual figure was $352000.0, up 24.82% from the prior year.
  • Current Leases was $361000.0 for Q1 2026 at CVRx, up from $352000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $361000.0 in Q1 2026 to a low of $170000.0 in Q3 2023.
  • Historically, Current Leases has averaged $264266.7 across 5 years, with a median of $247000.0 in 2024.
  • The sharpest annual moves came in 2023 and 2024: Current Leases advanced 4.05% in 2023, then soared 61.76% in 2024.
  • A 5-year view of Current Leases shows it stood at $222000.0 in 2022, then rose by 4.05% to $231000.0 in 2023, then gained by 22.08% to $282000.0 in 2024, then rose by 24.82% to $352000.0 in 2025, then gained by 2.56% to $361000.0 in 2026.
  • The last three Current Leases figures came in at $361000.0 (Q1 2026), $352000.0 (Q4 2025), and $342000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 24.30 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 20.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 35.80 Mn
10 CVRx 130.46 Mn 58.16 Mn 12.88 Mn 361,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 361,000.00
Dec 31, 2025 352,000.00
Sep 30, 2025 342,000.00
Jun 30, 2025 333,000.00
Mar 31, 2025 290,000.00
Dec 31, 2024 282,000.00
Sep 30, 2024 275,000.00
Jun 30, 2024 247,000.00
Mar 31, 2024 239,000.00
Dec 31, 2023 231,000.00
Sep 30, 2023 170,000.00
Jun 30, 2023 185,000.00
Mar 31, 2023 227,000.00
Dec 31, 2022 222,000.00
Mar 31, 2022 208,000.00